Literature DB >> 28558309

Reduced frequency of murine cytomegalovirus retinitis in C57BL/6 mice correlates with low levels of suppressor of cytokine signaling (SOCS)1 and SOCS3 expression within the eye during corticosteroid-induced immunosuppression.

Christine I Alston1, Richard D Dix2.   

Abstract

AIDS-related human cytomegalovirus retinitis remains a leading cause of blindness worldwide. We compared two C57BL/6 mouse models of experimental murine cytomegalovirus (MCMV) retinitis for intraocular expression of suppressors of cytokine signaling (SOCS)1 and SOCS3, host proteins that are inducible negative feedback regulators of cytokine signaling. These mouse models differed in method of immune suppression, one by retrovirus-induced immune suppression (MAIDS) and the other by corticosteroid-induced immune suppression. Following subretinal injection of MCMV to induce retinitis, intraocular SOCS1 and SOCS3 were only mildly stimulated, and often without significance, within MCMV-infected eyes during the progression of MCMV retinitis in corticosteroid-immunosuppressed mice, contrary to MCMV-infected eyes of mice with MAIDS that showed significant high stimulation of SOCS1 and SOCS3 expression in agreement with previous findings. Frequency and severity of retinitis as well as amounts of intraocular infectious MCMV in corticosteroid-immunosuppressed mice were also unexpectedly lower than values previously reported for MAIDS animals during MCMV retinitis. These data reveal a major difference between two mouse models of experimental MCMV retinitis and suggest a possible link between the amplitude of SOCS1 and SOCS3 stimulation and severity of disease in these models.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  AIDS-related cytomegalovirus retinitis; Corticosteroids; MAIDS; Murine cytomegalovirus; SOCS1; SOCS3; Suppressors of cytokine signaling (SOCS)

Mesh:

Substances:

Year:  2017        PMID: 28558309      PMCID: PMC5517024          DOI: 10.1016/j.cyto.2017.05.021

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  15 in total

1.  Lack of iNOS facilitates MCMV spread in the retina.

Authors:  Ming Zhang; Jun Zhou; Brendan Marshall; Hua Xin; Sally S Atherton
Journal:  Invest Ophthalmol Vis Sci       Date:  2007-01       Impact factor: 4.799

2.  Murine cytomegalovirus downregulates interleukin-17 in mice with retrovirus-induced immunosuppression that are susceptible to experimental cytomegalovirus retinitis.

Authors:  Emily L Blalock; Hsin Chien; Richard D Dix
Journal:  Cytokine       Date:  2013-02-14       Impact factor: 3.861

3.  Glucocorticoids target suppressor of cytokine signaling 1 (SOCS1) and type 1 interferons to regulate Toll-like receptor-induced STAT1 activation.

Authors:  Sandip Bhattacharyya; Yuxing Zhao; Thomas W H Kay; Louis J Muglia
Journal:  Proc Natl Acad Sci U S A       Date:  2011-05-23       Impact factor: 11.205

4.  Lack of TNF-alpha promotes caspase-3-independent apoptosis during murine cytomegalovirus retinitis.

Authors:  Ming Zhang; Jason Covar; Brendan Marshall; Zheng Dong; Sally S Atherton
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-03-28       Impact factor: 4.799

Review 5.  Viral exploitation of host SOCS protein functions.

Authors:  Lisa Nowoslawski Akhtar; Etty N Benveniste
Journal:  J Virol       Date:  2010-11-17       Impact factor: 5.103

6.  Glucocorticoids increase interleukin-6-dependent gene induction by interfering with the expression of the suppressor of cytokine signaling 3 feedback inhibitor.

Authors:  Anna Dittrich; Christina Khouri; Sara Dutton Sackett; Christian Ehlting; Oliver Böhmer; Ute Albrecht; Johannes G Bode; Christian Trautwein; Fred Schaper
Journal:  Hepatology       Date:  2012-01       Impact factor: 17.425

Review 7.  SOCS proteins, cytokine signalling and immune regulation.

Authors:  Akihiko Yoshimura; Tetsuji Naka; Masato Kubo
Journal:  Nat Rev Immunol       Date:  2007-05-18       Impact factor: 53.106

8.  Systemic reduction of interleukin-4 or interleukin-10 fails to reduce the frequency or severity of experimental cytomegalovirus retinitis in mice with retrovirus-induced immunosuppression.

Authors:  Emily L Blalock; Hsin Chien; Richard D Dix
Journal:  Ophthalmol Eye Dis       Date:  2012-09-25

9.  Nonprofessional phagocytosis can facilitate herpesvirus entry into ocular cells.

Authors:  Vaibhav Tiwari; Deepak Shukla
Journal:  Clin Dev Immunol       Date:  2012-03-15

10.  Murine cytomegalovirus infection of mouse macrophages stimulates early expression of suppressor of cytokine signaling (SOCS)1 and SOCS3.

Authors:  Christine I Alston; Richard D Dix
Journal:  PLoS One       Date:  2017-02-09       Impact factor: 3.240

View more
  5 in total

1.  Suppressor of Cytokine Signaling 1 (SOCS1) and SOCS3 Are Stimulated within the Eye during Experimental Murine Cytomegalovirus Retinitis in Mice with Retrovirus-Induced Immunosuppression.

Authors:  Hsin Chien; Christine I Alston; Richard D Dix
Journal:  J Virol       Date:  2018-08-29       Impact factor: 5.103

Review 2.  SOCS and Herpesviruses, With Emphasis on Cytomegalovirus Retinitis.

Authors:  Christine I Alston; Richard D Dix
Journal:  Front Immunol       Date:  2019-04-11       Impact factor: 7.561

3.  Atypical cytomegalovirus retinal disease in pyroptosis-deficient mice with murine acquired immunodeficiency syndrome.

Authors:  Jessica J Carter; Judee Grace E Nemeno; Jay J Oh; John E Houghton; Richard D Dix
Journal:  Exp Eye Res       Date:  2021-06-05       Impact factor: 3.770

4.  Evidence for the involvement of interleukin-1α during development of experimental cytomegalovirus retinitis in immunosuppressed mice.

Authors:  Gisseth A Mora Scarpetta; Jessica J Carter; Judee Grace E Nemeño; Richard D Dix
Journal:  Cytokine       Date:  2021-05-30       Impact factor: 3.926

5.  Transcriptional analysis of immune response genes during pathogenesis of cytomegalovirus retinitis in mice with murine acquired immunodeficiency syndrome.

Authors:  Jessica J Carter; Jesse M Gardner; Brent P Poling; Madeline M Welch; Judee Grace E Nemeno; John E Houghton; Richard D Dix
Journal:  PLoS Pathog       Date:  2020-11-06       Impact factor: 6.823

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.